Nature’s Sunshine Products (NASDAQ:NATR) Coverage Initiated by Analysts at Canaccord Genuity Group

Canaccord Genuity Group began coverage on shares of Nature’s Sunshine Products (NASDAQ:NATRFree Report) in a report issued on Friday, Briefing.com reports. The firm issued a buy rating and a $18.00 price target on the stock.

Several other brokerages also recently issued reports on NATR. StockNews.com upgraded Nature’s Sunshine Products from a buy rating to a strong-buy rating in a report on Tuesday. DA Davidson dropped their target price on Nature’s Sunshine Products from $23.00 to $21.00 and set a buy rating on the stock in a report on Monday, August 12th.

Check Out Our Latest Report on Nature’s Sunshine Products

Nature’s Sunshine Products Price Performance

NASDAQ NATR opened at $14.06 on Friday. The business’s 50-day simple moving average is $14.45 and its 200-day simple moving average is $16.40. The firm has a market capitalization of $260.25 million, a P/E ratio of 16.54 and a beta of 0.87. Nature’s Sunshine Products has a 1-year low of $10.81 and a 1-year high of $21.72.

Nature’s Sunshine Products (NASDAQ:NATRGet Free Report) last announced its quarterly earnings results on Thursday, August 8th. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.18). Nature’s Sunshine Products had a net margin of 3.50% and a return on equity of 9.79%. The business had revenue of $110.55 million for the quarter.

Institutional Trading of Nature’s Sunshine Products

A number of hedge funds and other institutional investors have recently modified their holdings of NATR. Dimensional Fund Advisors LP grew its stake in Nature’s Sunshine Products by 4.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 786,966 shares of the company’s stock valued at $11,860,000 after purchasing an additional 34,996 shares in the last quarter. Paradigm Capital Management Inc. NY grew its position in shares of Nature’s Sunshine Products by 26.8% during the second quarter. Paradigm Capital Management Inc. NY now owns 695,079 shares of the company’s stock worth $10,475,000 after buying an additional 146,879 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Nature’s Sunshine Products by 0.6% in the first quarter. Vanguard Group Inc. now owns 659,686 shares of the company’s stock worth $13,702,000 after buying an additional 3,792 shares during the last quarter. Renaissance Technologies LLC raised its holdings in Nature’s Sunshine Products by 1.9% in the second quarter. Renaissance Technologies LLC now owns 559,797 shares of the company’s stock valued at $8,436,000 after acquiring an additional 10,700 shares in the last quarter. Finally, Wasatch Advisors LP boosted its stake in Nature’s Sunshine Products by 20.6% during the 1st quarter. Wasatch Advisors LP now owns 518,161 shares of the company’s stock valued at $10,762,000 after acquiring an additional 88,433 shares during the last quarter. 79.40% of the stock is owned by hedge funds and other institutional investors.

Nature’s Sunshine Products Company Profile

(Get Free Report)

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.

Featured Stories

Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.